iSERA LIFESCIENCES share price
BSE: 534920IT - SoftwareSmall Cap
iSERA LIFESCIENCES LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2013
Last close ₹143.90₹0.00 (0.00%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹143.90.
28 Oct: open ₹143.90, high ₹143.90, low ₹143.90
52-week range of traded prices to 28 Oct 2026
₹7.99Low, 30 Oct 2025₹151.05High, 17 Sep 2026
- Under BSE's graded surveillance, stage 0, on the list for 27 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹354 Cr3,450th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- −0.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 200
Results
Standalone, as consolidated accounts are on record for only 2 of the last ten years; ₹ crore.iSERA LIFESCIENCES quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- –
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- −145.8%
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹0.00 Crdown 100.00%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing. Net profit in the glossary
- −₹0.34 CrQuarter to Mar 2026: ₹0.55 Cr
Revenue by quarter
Peak revenue ₹1.16 Cr, quarter to Mar 2026; lowest ₹0.00 Cr, quarter to Sep 2024
Net profit by quarter, a loss in red
- Net profit
- Loss
A loss in the quarter to Jun 2026, −₹0.34 CrA loss in 5 of the 8 quarters shown
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.19 | 1.16 | 0.00 |
| Net profit | −0.01 | −0.07 | 0.23 | −0.02 | 0.01 | −0.28 | 0.55 | −0.34 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary | – | – | – | – | – | −146.0% | 47.3% | – |
Standalone. The last eight quarters. The latest is shaded.
Year to Mar 2026, against the year before
- RevenueRevenue. Under it, revenue in the year before. A change in per cent is not worked out where either period is a loss or nothing.
- ₹1.36 CrYear to Mar 2025: ₹0.00 Cr
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.26 Crup 86.62%
- Net margin
- 19.1%
Revenue by year
Peak revenue ₹29 Cr, year to Mar 2018; lowest ₹0.00 Cr, year to Mar 2021
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 6 of the 10 years shown
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21.4 | 28.9 | 12.3 | 2.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.4 |
| Net profit | 0.0 | 0.0 | 0.0 | −0.4 | −0.2 | 0.0 | −0.1 | −0.1 | 0.1 | 0.3 |
| Net margin | 0.0% | 0.1% | −0.1% | −19.6% | – | – | – | – | – | 19.1% |
Standalone. Years to March. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, IT Sector Company, which carries all its revenue.
Promoter and insider buying and selling
Trades made since 29 Oct 2025.iSERA LIFESCIENCES insider trading
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade · 30 off-market moves
- Directors and key managers: no market trade · 1 off-market move
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
iSERA LIFESCIENCES competitors and peers
Computers - Software & Consulting, 99 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to iSERA LIFESCIENCES in market cap.IT companies
iSERA LIFESCIENCES is not on the chart: it has no P/E today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Mindteck (India)MINDTECK | 427 | 13.70 | 1.41 | −1.8% | +0.3% | 11.0% | 10.5% | 0.75% |
 3i Infotech3IINFOLTD | 415 | 12.09 | 1.09 | −2.2% | – | 10.0% | −6.8% | 0.00% |
 Covance SoftsolCOVANCE | 382 | 9.73 | 2.27 | – | – | 30.2% | 21.0% | 0.00% |
 Cybertech Systems and SoftwareCYBERTECH | 373 | 11.74 | 1.81 | +10.5% | −10.4% | 15.9% | 9.5% | 3.26% |
 Xtglobal InfotechXTGLOBAL | 341 | 29.06 | 1.67 | +33.4% | +18.3% | 6.1% | 8.1% | 0.20% |
 Systango TechnologiesSYSTANGO | 318 | 9.99 | 2.35 | +34.6% | +34.3% | 26.8% | – | 3.22% |
 Ace Alpha TechACEALPHA | 263 | 17.33 | 3.81 | +56.0% | +35.7% | 29.8% | – | 0.00% |
 Fidel SoftechFIDEL | 248 | 18.35 | 4.43 | – | – | 26.7% | – | 1.25% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.iSERA LIFESCIENCES dividend history
| Ex-date | Type | Per share |
|---|---|---|
| 20 Sep 2013 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. Final dividend in the glossary | ₹0.50 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.iSERA LIFESCIENCES announcements
Oct 2026
8 Oct · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
iSERA LIFESCIENCES share price by year
Each calendar year to 2025.iSERA LIFESCIENCES share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 16.98 | +736.5% | 16.98 | 1.57 |
| 2024 | 2.03 | +14.0% | 2.03 | 1.78 |
| 2023 | 1.78 | +36.9% | 1.78 | 1.30 |
| 2022 | 1.30 | +36.8% | 1.30 | 0.94 |
| 2021 | 0.95 | +46.2% | 1.00 | 0.65 |
| 2020 | 0.65 | −3.0% | 0.67 | 0.65 |
| 2019 | 0.67 | −28.0% | 0.93 | 0.53 |
| 2018 | 0.93 | −8.8% | 1.44 | 0.72 |
| 2017 | 1.02 | −72.8% | 4.50 | 0.76 |
| 2016 | 3.75 | −60.9% | 9.40 | 2.33 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2025 is from its first session, 3 Jul 2025. 2021 is from its first session, 1 Mar 2021. 2019 is from its first session, 21 Jan 2019. The close is the year's last trade for 2024 (18 Mar 2024), 2020 (9 Mar 2020) and 2018 (19 Dec 2018).
Recent sessions
The 9 trading days to 26 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 26 Oct 2026 | 143.90 | 143.90 | 143.90 | 143.90 | 143.90 | 153 |
| 23 Oct 2026 | 143.90 | 143.90 | 143.90 | 143.90 | 143.90 | 1,471 |
| 21 Oct 2026 | 143.90 | 143.90 | 143.90 | 143.90 | 143.90 | 19,994 |
| 16 Oct 2026 | 143.90 | 143.90 | 143.90 | 143.90 | 143.90 | 31 |
| 15 Oct 2026 | 143.90 | 143.90 | 143.90 | 143.90 | 143.90 | 720 |
| 14 Oct 2026 | 143.90 | 143.90 | 143.90 | 143.90 | 143.90 | 14 |
| 13 Oct 2026 | 143.90 | 143.90 | 143.90 | 143.90 | 143.90 | 16 |
| 8 Oct 2026 | 143.90 | 143.90 | 143.90 | 143.90 | 143.90 | 1,190 |
| 6 Oct 2026 | 143.90 | 143.90 | 143.90 | 143.90 | 143.90 | 1,000 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Open offer history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 24 Oct 2025 | Rights issue | – | Shareholders were offered new shares. Noted, not adjusted for. |
| 3 Jul 2025 | Price move | – | This is the share's first trade after a corporate action (Resolution Plan -Suspension, ex-date 22 Mar 2024), and the action's terms do not account for the move. Not adjusted for. |
Each event is noted and not adjusted for.
Company details
- BSE code
- 534920
- ISIN
- INE899M01020
- Industry
- IT - Software
- Website
- www.covidh.com
- CIN
- L72200TG1993PLC015306
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1993
- Registered office
- Office No. 4, Kumar Prestige Point, 238 Shukrawar Peth, Pune 411002, Maharashtra
- Share registrar
- Skyline Financial Services Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments